Background The impact of psychosocial states, such as depression or anxiety, and social support on the outcomes of stable outpatients with mild heart failure (HF) has not been evaluated in the "real world" clinical practice.
onsiderable evidence suggests a link between depression and the prognosis of patients with coronary heart disease, [1] [2] [3] [4] [5] [6] [7] and recently, the role of depression in patients with chronic heart failure (HF) has become the focus of many studies. [8] [9] [10] [11] [12] [13] [14] However, the impact of depression on prognosis has been less consistent in this disease state. 12, 15 Anxiety is often present concurrently with depression, so not only depression but also anxiety may be adversely associated with poor prognosis in HF. However, evidence supporting a prognostic impact of anxiety is poorly described and previous studies of the effects of depression and anxiety on the prognosis of patients with HF found that poor outcomes were associated with depression, but not with anxiety. 12, 15 Importantly, those reports studied selected patients with HF, such as hospitalized patients, 10, 12 and those with low ejection fraction (EF <35%). 16, 17 Therefore, the impact of depression, as well as anxiety, on the outcomes of stable outpatients with mild (New York Heart Association (NYHA) functional class I or II) HF has not been evaluated in the "real world" clinical practice. Moreover, the contribution of psychosocial factors to the presence of anxiety has not been studied in HF patients.
Therefore, the purpose of the present study was to determine if depression and anxiety are associated with adverse outcomes in patients with HF and to identify the independent determinants of these psychological states.
Methods

Study Patients
A total of 139 outpatients with a prior history of hospital admission for HF in 5 cardiology units (1 university hospital and 4 teaching hospitals) were studied. The diagnosis of HF was ascertained according to the Framingham criteria. 18 Patients younger than 18 years old, those who had cognitive impairment or were unable to provide consent were excluded. No patients were taking antidepressants or anxiolytics. The research protocol was approved by the hospital's institutional review board and informed consent was given by each patient.
Demographic and Medical Characteristics
Detailed clinical data regarding (1) demography (including age and sex), (2) etiology of HF, (3) comorbidity, (4) severity of HF and exercise capacity, and (5) pharmacological or nonpharmacological treatments were collected from medical records using the abstraction form with slight modification used in our previous studies. [19] [20] [21] Ischemic heart disease was considered present if the patient had 1 of the following: (1) documented history of myocardial infarction, angina or prior coronary revascularization, (2) pathologic Q waves on ECG, (3) reversible defects on a thallium stress test, or (4) greater than 75% stenosis in 1 or more coronary arteries on angiography. Valvular heart disease was diagnosed on the basis of the presence of mitral or aortic valve disease documented by physical examination and echocardiography or angiography. Hypertensive heart disease was considered as an etiology of HF if there was a history of hypertension in the medical records or sustained hypertension (blood pressure >140/90 mmHg) and left ventricular (LV) hypertrophy confirmed by electrocardiography or echocardiography. Dilated cardiomyopathy was diagnosed by the presence of LV dilation with impaired systolic function occurring in the absence of known cardiac or systemic causes. Congenital heart disease was diagnosed from the echocardiographic or angiographic findings.
The presence of comorbidities such as hypertension, diabetes mellitus, hyperlipidemia, cerebrovascular disease, atrial fibrillation, and prior myocardial infarction were also identified as described previously. [19] [20] [21] LVEF on echocardiograms and brain natriuretic peptide (BNP) concentration were recorded. Exercise capacity was assessed by a specific activity scale.
Socio-Environmental Characteristics
Socio-environmental status included living alone, marital status, number of social ties, and employment. The level of perceived social support was quantitatively assessed by the Perceived Social Support Survey (PSSS) of Medical Outcome Study, 22 which has 4 subscales: (i) emotional support, (ii) tangible support, (iii) affectionate support, and (iv) positive social interaction. Each score ranges from 0 to 100, with higher scores indicating a higher level of perceived social support. Emotional support is defined as empathy and understanding, having positive effects, and encouraging expressions of feelings. Tangible support is the provision of concrete aid and assistance, such as financial, transportation, or housekeeping help. Affectionate support is having someone who expresses love and affection. Positive social interaction is defined as having people with whom one can share social activities. A total score was obtained by calculating the mean value of the 4 scales.
Depression and Anxiety
The beck depression inventory (BDI: second version) was used to measure the depressive state of the studied patients. It is a self-administrated, 21-item questionnaire that has been established for the screening of depressive symptoms in various populations. The severity of depression was categorized as absent (0-13), mild (14) (15) (16) (17) (18) (19) , moderate (20) (21) (22) (23) (24) (25) (26) (27) (28) or severe (≥29). These cutoff values have been verified for the likelihood for detecting depressive symptoms of Japanese subjects. 23 State anxiety reflects how a patient generally feels and was assessed by the state-trait anxiety inventory (STAI). 24 The cutoff values of 40 for men and 42 for women were used to identify the presence of anxiety. 25 
Follow-up Information
Follow-up information was obtained 1 year after initial assessment from medical records and also via direct contact by mail or telephone. The following information was obtained: (1) death or hospital re-admission because of exacerbation of HF that required more than continuation of the usual therapy on admission, and (2) cause of death. Cardiovascular death and re-admission because of HF were defined as cardiovascular events. Follow-up information was obtained from all patients.
Statistical Analysis
All data are expressed as means ± SD. We performed linear regression analysis to identify the predictors of depression and anxiety. To determine independent predictors of clinical outcomes, including cardiac death or HF-related re-admission, we performed univariate analysis to compare all variables between patients with and without events. Chi-square or t-test was used to determine differences in demographic characteristics, etiology, comorbidity, disease severity, pharmacological or nonpharmacological treatment, socio-environmental status, and psychological status. We used all variables significantly (P<0.05) identified by the univariate analysis as candidate variables and entered them into a Cox proportional hazard model to identify predictors of cardiac death or HF-related re-admission. Relative risk and 95% confidence interval were calculated for these predictors. Survival function estimates, as well as cardiac death or HF-related re-admission rates during the follow-up period, were derived using the methods of Kaplan and Meier and the differences between psychological states were assessed by the log-rank test. A value of P<0.05 was considered statistically significant. We performed all statistical analyses with SPSS 14.0J for Windows (Chicago, IL, USA).
Results
Demographic and Medical Characteristics (Table 1)
At the time of initial assessment, the mean age was 68 years (range, 25-87), and 37% of patients were older than 75 years of age. Overall, 66% were male and 34% were female. Common types of HF were ischemic (31% of patients), cardiomyopathic (34%), hypertensive (24%), and valvular (24%). The majority of the patients (84%) were in NYHA functional class I or II. Mean LVEF was 48.2% and 38% had LVEF <40%. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers were administrated to 78%, β-blockers to 56%, and diuretics to 68% of patients.
Socio-Environmental Characteristics (Table 2)
Of the total patient group, 16% lived alone, and 69% were married. Half of patients had none or less than 3 social ties. Most patients had no occupation. The mean total PSSS score was 71.4. The score of positive social interaction was relatively lower than other subscales in the PSSS.
Depression and Anxiety and Their Predictors
We found that 37% of patients had depression (BDI score >13); 25% had mild depression (BDI score 13-19) and for 
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12% it was moderate (BDI score 20-28) ( Table 2) ; none had severe depression. According to the STAI scores (>40 in males, >42 in females), 37% had anxiety. The BDI score had a high correlation with the STAI score (r=0.503; P<0.01) (Fig 1A) . The BDI and STAI scores each inversely correlated with the PSSS score (r=-0.423 and r=-0.466, respectively; P<0.01) (Figs 1B,C) . Patients with high BDI and STAI scores had a lower PSSS score. Moreover, the PSSS score of the patients who had depression and anxiety was less than that of the patients who did not have depression and anxiety and that of the patients who had either (Fig 2) . Independent determinants of depression were male gender (sβ=-0.36, P=0.01), social ties (sβ=0.22, P=0.04) and low social support (sβ=-0.39, P<0.01) ( Table 3) . Independent determinants of anxiety included alcohol drinking (sβ=0.22, P=0.04), BNP ≥200 pg/dl (sβ=0.35, P<0.01), and low social support (sβ=-0.28, P=0.01) ( Table 4) .
Patient Outcomes
During a mean follow-up of 1 year, 36 patients had cardiovascular events: 35 (25.2%) were admitted to the hospital because of worsening HF and 1 patient (0.7%) was re-admitted because of HF and subsequently died. Because there was only 1 cardiovascular death during the follow-up, we used HF-related re-admission as an outcome of this study. Compared with patients without events, patients with HF-related re-admission were older and had a higher prevalence of cerebrovascular disease and atrial fibrillation ( Table 1) . However, NYHA functional class, etiology of HF, LVEF, and medications used were comparable between the groups ( Table 1) . Patients with HF-related re-admission had a lower score for the PSSS, especially the total PSSS score as well as the scores for affectionate and positive social interactions ( Table 2) .
The BDI depression score was comparable between patients with and without HF-related re-admission, whereas the STAI anxiety score was higher in patients with HF-related re-admission (P=0.01) ( Table 2) .
Kaplan-Meier survival curves of the study patients divided by BDI depression score, STAI anxiety score and PSSS score are shown in Fig 3. Patients with anxiety had higher rates of HF-related re-admission (Fig 3B) . Patients with lower scores for the PSSS had a higher rate of HF-related re-admission (P<0.01, Fig 3C) . In contrast, depression did not affect these outcomes (Fig 3A) . Controlling for demographic, medical, and socio-environmental variables in the multivariate Cox regression model, anxiety was the most powerful independent predictor of HF-related re-admission ( Table 5) . Patient with anxiety had 3.5-fold higher risk for HF-related re-admission. Low social support, high BNP, prior cerebrovascular disease, and atrial fibrillation were also identified as significant determinants of adverse outcomes.
Discussion
The present study demonstrated that depression and anxiety are common in stable outpatients with mild HF. Low scores for the PSSS were associated with depression and anxiety, and anxiety and low social support were independently associated with a higher incidence of HF-related re-admission to hospital.
Depression, Anxiety, and Social Support in HF Patients
The prevalence of depression in our study patients was 37%, and previous studies have reported values ranging from 13% to 48% among outpatients with HF. [13] [14] [15] 26 The prevalence of depression in HF patients is affected by the method of assessment, the definition and classification of depression, and the severity of HF in the study patients. 27 In addition, HF-specific symptoms, such as fatigue, insomnia, and loss of appetite, may overlap with the symptoms of depression. 28 Nevertheless, our results, as well as those from previous studies, have consistently shown that depression is common in patients with HF.
The prevalence of anxiety was also as high, at 40%, in the present study, and previous studies have reported values of 45% 15 and 63%. 4 These values are higher than those in patients with other cardiac diseases, 29, 30 so anxiety is also common in patients with HF.
There have been only a few studies that have determined the risk factors for depression or anxiety in HF patients. In the present study depression was associated with living alone and poor social support. In contrast, medical factors such as etiology, comorbidity, complication and the severity of HF were not associated with depression, suggesting that depression is caused by social rather than medical status. 28 Female patients were likely to have depression than male patients ( Table 4) . Although the reason for this gender difference is unclear, this may explain the results of a previous study by Krumholz et al, in which emotional support was effective in improving the outcomes only in female patients. 8 Alcohol drinking was also associated with anxiety, and mental health has been shown to be a significant predictor of dietary and exercise adherence, 31 so anxiety may lead to an unhealthy lifestyle in patients with HF. 27 Anxiety was associated with BNP level, suggesting that the severity of HF may affect the level of anxiety. Social factors were important predictors for depression and anxiety, suggesting that social support is an essential component of the management of HF patients.
Anxiety, Social Support, and Outcomes of HF Patients
An important finding of this study was that anxiety and poor social support were strongly associated with adverse outcomes in HF patients, even after adjusting for demographic and medical variables. There are only a few studies that have determined the impact of anxiety and social support on the outcomes in patients with HF. Riedinger et al demonstrated that anxiety was an independent predictor of adverse cardiac events in patients with recent myocardial infarction and low EF. 32 In contrast, other studies reported that anxiety did not predict rehospitalization or mortality. 15, 33 The reasons for these discrepancies are not clear; however, they might be related to differences in the definition and measurement of anxiety.
We demonstrated that social support was an independent predictor of adverse outcomes in patients with HF, which is consistent with previous studies showing that social isolation and lack of social ties or support are related to the risk of adverse outcomes. 8, 34 A recent study also confirmed the association between the magnitude and satisfaction of social support and mortality in HF outpatients. 15 However, those studies used relatively simple measures to assess the level of social support. In the study by Krumholz et al, 8 the emotional support was defined as being able to count on someone to talk over problems and help with daily tasks. The present study assessed the level of social support by using the PSSS of the Medical Outcome Study, a multidimensional and quantitative questionnaire. 22 Although other studies have identified depression as a prognostic predictor in patients with HF, 9-13 we could not find an association between depression and adverse outcomes in the present study. One of the reasons for this discrepancy is the high functional status and low severity of HF of this study's subjects because low functional status, including limitation in activities of daily living and dyspnea at rest, has been strongly shown as associated with depression among HF patients. 10 There are 2 potential mechanisms linking anxiety and low social support with adverse outcomes in HF patients: a behavioral pathway and a biological pathway. 27 With respect to the behavioral pathway, psychological factors can affect adherence to medications and lifestyle modifications. 35 In our previous study, 40% of HF-related re-admissions were because of noncompliance with both the salt limit in the diet and medical treatment. 19 Social support may improve the patient's adherence to the medical treatment via not only the tangible support to daily life but also the mitigation of symptoms of anxiety. These effects are expected to reduce the risk for adverse outcomes in HF patients. Biological mechanisms consist of the activation of the sympathetic nervous system, as represented by a reduction in heart rate variability and impaired vagal control, 36 in hypercortisolemia. 37 and in the elevated levels of proinflammatory cytokines. 38 
Study Limitations
First, the duration of depression and anxiety during follow-up was not assessed. Second, the duration of follow-up was 1 year and only 1 cardiovascular death occurred during this period of time. Therefore, the long-term effects of psychological factors on adverse outcomes require further investigation. Despite these limitations, the significant association between psychosocial factors and adverse outcomes is considered to be valid, even in patients with mild symptoms of HF.
Conclusions
Anxiety and low social support increase the risk for HFrelated re-admission of stable outpatients with mild HF. Psychosocial factors need to be incorporated into the assessment of HF patients. Moreover, interventions to improve psychological status and reinforce social support are needed in the management of HF.
